IL217523A0 - Anti-influenza agents - Google Patents

Anti-influenza agents

Info

Publication number
IL217523A0
IL217523A0 IL217523A IL21752312A IL217523A0 IL 217523 A0 IL217523 A0 IL 217523A0 IL 217523 A IL217523 A IL 217523A IL 21752312 A IL21752312 A IL 21752312A IL 217523 A0 IL217523 A0 IL 217523A0
Authority
IL
Israel
Prior art keywords
influenza agents
influenza
agents
Prior art date
Application number
IL217523A
Other languages
English (en)
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009903329A external-priority patent/AU2009903329A0/en
Application filed by Univ Griffith filed Critical Univ Griffith
Publication of IL217523A0 publication Critical patent/IL217523A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL217523A 2009-07-16 2012-01-12 Anti-influenza agents IL217523A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009903329A AU2009903329A0 (en) 2009-07-16 Anti-influenza agents
PCT/AU2010/000905 WO2011006208A1 (en) 2009-07-16 2010-07-16 Anti -influenza agents

Publications (1)

Publication Number Publication Date
IL217523A0 true IL217523A0 (en) 2012-02-29

Family

ID=43448806

Family Applications (1)

Application Number Title Priority Date Filing Date
IL217523A IL217523A0 (en) 2009-07-16 2012-01-12 Anti-influenza agents

Country Status (11)

Country Link
US (1) US20120202877A1 (enExample)
EP (1) EP2454248A4 (enExample)
JP (1) JP2012532894A (enExample)
CN (1) CN102612514B (enExample)
AU (1) AU2010273184B2 (enExample)
CA (1) CA2768081A1 (enExample)
IL (1) IL217523A0 (enExample)
MX (1) MX2012000576A (enExample)
RU (1) RU2012105073A (enExample)
SG (1) SG177633A1 (enExample)
WO (1) WO2011006208A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
JP6786095B2 (ja) * 2016-07-27 2020-11-18 国立研究開発法人理化学研究所 シアル酸類縁体
EP3630740A4 (en) * 2017-05-25 2021-03-31 The Governors of the University of Alberta METHOD OF PREVENTION OR TREATMENT OF ATHEROSCLEROSIS WITH INHIBITORS OF SPECIFIC ISOENZYMS OF HUMAN NEURAMINIDASES
CA3148756A1 (en) * 2019-07-30 2021-02-04 Griffith University Antiviral agents and uses thereof
US12116382B2 (en) 2022-11-28 2024-10-15 Hongene Biotech Corporation Functionalized N-acetylgalactosamine analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
JPH11279168A (ja) * 1996-07-22 1999-10-12 Sankyo Co Ltd ノイラミン酸誘導体
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US7045535B2 (en) * 2001-03-08 2006-05-16 Biocryst Pharmaceuticals, Inc. Compounds useful for inhibiting paramyxovirus neuraminidase

Also Published As

Publication number Publication date
JP2012532894A (ja) 2012-12-20
CN102612514B (zh) 2016-01-13
EP2454248A4 (en) 2013-04-03
EP2454248A1 (en) 2012-05-23
AU2010273184A1 (en) 2012-03-01
CN102612514A (zh) 2012-07-25
AU2010273184B2 (en) 2015-07-09
WO2011006208A1 (en) 2011-01-20
MX2012000576A (es) 2012-07-20
CA2768081A1 (en) 2011-01-20
US20120202877A1 (en) 2012-08-09
SG177633A1 (en) 2012-02-28
RU2012105073A (ru) 2013-08-27

Similar Documents

Publication Publication Date Title
IL230542B (en) Anti-inflammatory factors
GB0908957D0 (en) Therapeutic agents
IL233822A0 (en) New anti-inflammatory agents
PL2403852T3 (pl) 2-aminobenzoimidazolo-5-karboksyamidy jako środki przeciwzapalne
GB0919432D0 (en) Use
GB0900914D0 (en) Antiviral agents
IL220526A0 (en) Kokumi-imparting agent
IL220527A0 (en) Kokumi-imparting agent
GB0922505D0 (en) Use
IL217523A0 (en) Anti-influenza agents
IL218500A0 (en) Apogossypolone derivatives as anticaner agents
PL2427617T3 (pl) Okucie
AP2685A (en) Sulfamoyl-phenyl-ureido benzamidine-derivatives asantimalarial agents
GB2479686B (en) Processors
GB0910493D0 (en) Therapeutic agents
GB0917304D0 (en) Use
AU2009903329A0 (en) Anti-influenza agents
GB0919819D0 (en) Therapeutic agents
GB0911965D0 (en) Therapeutic agents
GB0915586D0 (en) Therapeutic agents
GB0903949D0 (en) Therapeutic agents
GB0907971D0 (en) Therapeutic agents
GB0919820D0 (en) Therapeutic agents
GB0919824D0 (en) Therapeutic agents
GB0914533D0 (en) Therapeutic agents